Prof. Masao Omata was the Chairman of the Department of Gastroenterology at the University of Tokyo, Japan. He graduated from the Chiba University School of Medicine and continued his training at Yale University, USA and in the Liver Unit at the University of Southern California. In 1992, he became Chairman of the Second Department of Internal Medicine at the University of Tokyo, Japan and then subsequently became Chairman of the Department of Gastroenterology. Under his leadership, the Department of Gastroenterology had become one of the foremost centers in its field.
In 2009, he was promoted to become the president of two hospitals: Yamanashi Central and Kita Hospitals to upgrade the medical care system in Yamanashi Prefecture, west of Tokyo, where, although scenic place with Mt. Fuji, hepatitis virus infection is endemic. The governor of Yamanashi has asked Prof. Omata to combat with the liver diseases of his homeland under his expertise and also run the two hospitals as a president.
Prof. Omata has made numerous seminal contributions to the fields of gastroenterology, hepatology, HBV and HCV, including the first description of the association between pre-core HBV mutants and fulminant hepatitis (N Engl J Med 1991), and the extremely high eradication rate of acute HCV by interferon (Lancet 1991). In addition, his group was the first to document the presence of cccDNA of HBV in human samples as a key marker of antiviral resistance (Hepatology 1985). Other major contributions include the emphasis of a viral etiology for hepatocellular carcinoma in 1970s in the USA (Gastroenterology 1979), as well as the first description of ‘fibrolamellar carcinoma’ (Cancer 1980).
He also demonstrated that the eradication of HCC decreased the incidence to one-fifth of the untreated, and fibrosis regression rate was 0.28 Fibrosis Stages/year. He also has established the largest volume center of HCC treatment by educating more than 200 young hepatologists and gastroenterologists at the University of Tokyo.
He has published over 950 articles in peer-reviewed English journals (5 N Engl J Med, 6 Lancet, 40 Gastroenterology, 53 Hepatology) in all disciplines of gastroenterology and hepatology (total impact factors: 4145, total citations: 20375 times).
He was the Presidents of the 17th Asian Pacific Association for the Study of the Liver (APASL) in 2007 and the 50th Japanese Society of Gastroenterology meeting in 2008. Currently, he is in charge of APASL-Tokyo-Secretariat.
HBV; HCV; HCC
Prof. Shu-Kui Qin, President of Chinese Society of Clinical Oncology (CSCO) and Vice-President of Nanjing Bayi Hospital and Director of PLA Cancer Center, is a senior medical oncologist, especially focusing on the Gastro-intestinal cancer and Liver cancer.
Prof.Qin holds some important positions in a variety of international and domestic academic organizations, including Council Member of Asia Clinical Oncology Society (ACOS), Senior Council Member of Chinese Anti-Cancer Association (CACA), Vice- President of the National Committee for Cancer Palliative Therapy & Pain Control, Chair of Liver Cancer group of National Ministry of Health, etc. He acts as the Editor-in- Chief of “Journal of Chinese Clinical Oncology” and “The Oncologist (Chinese version) ” , the Associate Editor-in-Chief of “Chinese Clinical Oncology Year-Books”, “Journal of Cancer Research and Clinical” and “The Chinese-German Journal of Clinical Oncology” etc.
Up to now, Prof. Qin has published more than 400 medical papers and 45 academic works, has participated in more than 82 international multi-centers clinical trials and 51 domestic clinical trials. Prof. Qin’s outstanding contributions to both academic and research fields were highly rewarded including Special Talent Allowance of State Council and more than 16 Chinese National and Province scientific awards.
Gastro-intestinal cancer; liver cancer
Dr. Buell is the Director of the Tulane Transplant Institute and Director of Transplantation at the New Orleans Children’s Hospital, the Louisiana State University. Currently, Dr. Buell is a tenured Professor of Surgery and Pediatrics at Tulane University and the Louisiana State University. Dr. Buell has clinical interests in drug and medical device development including clinical immunology and stem cell technology. His medical interests are in health care disparity, medical economics, health policy, and systems development. Dr. Buell’s expertise is in liver and bile duct cancer, as well as solid organ and composite tissue transplantation.
Dr. Buell received his undergraduate from Fordham University in New York City and subsequently earned his medical degree from the University of Rochester, and a Mater’s of Business Administration from Tulane University. Dr. Buell completed his general surgery residency at the University of Maryland and Shock Trauma Center. Dr. Buell subsequently completed two fellowships, the first in surgical oncology at the National Cancer Center, National Institutes of Health and the second his multi-organ transplant fellowship at the University of Chicago. Dr. Buell has received numerous awards and fellowships including The Dr. Leak award from the American Cancer Society. Dr. Buell was trained as a basic scientist at the National Cancer Institute, National Institutes of Health and completed his post-doctoral research in the molecular mechanisms of DNA platination and the implications of hyperthermia and tumor necrosis factor in the modification of snip gene transcription.
Subsequently, Dr. Buell pioneered the field of laparoscopic liver surgery has become a thought leader in device development, clinical trials and translational research. Since his arrival in New Orleans he has re-organized and realigned the Tulane and Louisiana State University programs to provide comprehensive transplant and liver tumor care for adults and children in the greater Louisiana region. In this region with significant financial and racial disparity, Dr. Buell and his collaborator Dr. Friedlander have worked with the ministers of the Ninth Ward to address systemic and regional racial disparity to provide improved healthcare to the most financially disparite.
Transplantation & Hepatobiliary
4. Minimally invasive liver surgery
Guangwen Cao is the chairman of the Department of Epidemiology, Second Military Medical University (Shanghai, China). He was graduated from Second Military Medical University as PhD and MD student and received medical trainings in Baylor College of Medicine and University of Texas MD Anderson Cancer Center (Houston, USA). Prof. Cao serves as the principal scientist of the National Key Basic Research Program (973 program) in cancer research and the Distinguished Young Scholar in China. Prof. Cao has published 120 research papers in international journals.
Biomarkers and genetic disposition on carcinogenesis and metastasis of hepatocellular carcinoma; renal cell carcinoma; lung cancer; gastric cancer; colorectal carcinoma; infectious cause of hepatocellular carcinoma; interaction between hepatitis B virus and genetic predisposition on hepatocarcinogenesis; quick pathogen identification and epidemiological outbreak study of emerging infectious diseases of natural sources and manmade; disaster medicine
Prof. Farinati Fabio graduated in medicine and surgery with full marks and laude Padua University, Italy in 1978. then received his MD specialization in gastroenterology with full marks and Laude, Padua University in 1982, and PhD specialization in oncology, Padua University in 1987. Now he is the full professor of gastroenterology, department of surgical and gastroenterological sciences, Padua University. He has more than 280 publications in PubMed with an IF > 1,000 in highly ranked international scientific journals, 55 full papers in Italian journals, has written 42 book chapters.
GI cancerogenesis and clnical practice, with specific interest in gastric and liver cancer, precancerous conditions and lesions in esophagus and stomach.
•Responsible for grants by the Italian Ministry of Health and University and other private and public organization.
•Coordinator of the GENE group (Hepatocarcinoma Group North East Italy)
•Coordinator of the Section of Oncology of the Italian Society of Gastroenterology
•Vice President of the Italian Society of Gastroenterology
Mark Feitelson attended Cypress College (Cypress, CA) from 1970-72, and then received a BS degree in Biology from the University of California, Irvine in 1974. Advanced studies resulted in a PhD in Microbiology and Immunology from the UCLA School of Medicine in 1979. His thesis presented the genetic organization of the rabbit papilloma virus. He was then an American Cancer Society Postdoctoral fellow in the Department of Medicine at Stanford University from 1980-1982, where he started his work with hepatitis B virus (HBV). He was then recruited to the Fox Chase Cancer Center by Dr. Baruch Blumberg (who won the Nobel Prize for his discovery of HBV) where he continued his work in HBV. He is presently Professor of Biology at Temple University and Associate Director of the Temple Biotechnology Center. He has been consistently funded by NIH and foundations since 1988 for basic science work on HBV and has attracted 10 contracts from industry for translational and applied work since 1997. He has over 100 publications in highly ranked international scientific journals, has written two books; delivered more than 160 oral presentations and/or posters at national and international scientific meetings, and has delivered more than 100 invited lectureships all over the world.
Molecular pathogenesis of hepatitis B and C viruses in liver cancer; hepatitis B
Liver cancer and liver transplantation; tumor infiltration; metastasis and extended resection in liver; gallbladder and pancreas; as well as promotion of surgical technology innovation by combining medical science and engineering
Go Wakabayashi, earned his degrees from Keio University School of Medicine, Tokyo Japan. He was trained at Department of Surgery at Massachusetts General Hospital and Harvard Medical School. After working as an assistant professor at Department of Surgery, Keio University School of Medicine, he was recruited as professor and chairman of Department of surgery at Iwate Medical University School of Medicine in 2005. His expertise includes Hepato-pancreatic Biliary Surgery, liver transplantation, and laparoscopic surgery. He has operated more than 150 cases of living liver transplantation and over 3000 cases of HPB surgery and laparoscopic surgery. He was awarded Gold Medal of Video Olympics at The World Congress of Endoscopic Surgery 1996. He also practices conventional HPB surgery and aggressive surgery as well. He holds numerous important positions in Japanese and international surgical societies.
Hepato-pancreatic biliary surgery; liver transplantation; laparoscopic surgery; conventional HPB surgery and aggressive surgery
Professor Jun Yu is a Professor at Department of Medicine and Therapeutics, Director of the Research Laboratory of Institute of Digestive Disease, and Associate Director of State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong (CUHK). Prof Yu did her MD and PhD at Tongji Medical University and then she embarked on gastrointestinal specialist in Beijing University in 1994-1998, followed by a postdoctoral fellowship in the Department of Gastroenterology at the University of Dresden and University of Magdeburg, Germany and CUHK, Hong Kong, respectively in 1998-2002. She worked as a Senior Research Officer at University of Sydney in 2003-2005. She has been a CUHK faculty member since 2005. Her research interests are mainly on gastrointestinal cancers in relation to the genetic and epigenetic molecular mechanisms and cancer biomarkers. Serving as a member of International Cancer Genome Consortium (ICGC), she has also been involved in research on whole genome,exome and metagenome sequencing in gastrointestinal cancers. Prof Yu has over 280 publications in international peer-reviewed journals (51 papers with impact factor > 10) including Nature biotechnology, Cancer Cell, Cell Metabolism, J Clin Oncol, J Clin Invest, Gastroenterology, Gut, Nature communication, Hepatology, Cancer Res and Oncogene and 7 book or book chapters. She has obtained or filed 15 patents for cancer biomarkers. Her contributions to the advancement of medical sciences have been recognized with 15 prestigious awards.
Murine non-alcohol steatohepatitis (NASH) in relation to the mechanisms of development of experimental steatohepatitis; and treatment response
1. Gene modulation in protect against NASH
2. Identification of the epigenetic and genetic alterations in relation to the mechanisms of pathogenesis of hepatocellular carcinoma (HCC)
3. Identification of epigenetic and genetic targets in relation to early diagnosis and prognostic prediction of gastrointestinal cancers
• Identification and characterization of cancer related genes and micro-RNAs in hepatocellular, esophageal and nasopharyngeal carcinomas;
• Molecular characterization of tumor microenvironment, especially cancer fibroblasts secreted proteins.
Dr. Kwee is director for PET Research of the Queen's Medical Center and an associate professor of John A. Burns School of Medicine, University of Hawaii at Manoa. He is the principal investigator of NCI funded clinical trials (NCT00928252 and NCT00928174) evaluating an investigational positron tomography (PET) diagnostic for liver and prostate cancers. Recent work has also involved the analysis of free circulating nucleic acids as a complement to imaging biomarkers, PET-guided radiation therapy planning, and using PET imaging as a means to annotate tissue gene expression profiling. Another research-relevant interest is biomedical ethics.
Positron tomography; Imaging biomarkers; Radiation therapy; Cancer diagnostic
Tan To Cheung, MBBS, MS, FRCS(Ed), FCSHK, FHKAM, is the Chief of the Division of Hepatobiliary and Pancreatic Surgery within the Department of Surgery, Queen Mary Hospital, the University of Hong Kong, and a Council member of the Hong Kong Society of Hepatobiliary and Pancreatic Surgery. He is also Associate Professor of Surgery at the University of Hong Kong.
Dr. Cheung received his medical degree from the University of Hong Kong. After graduation, Dr. Cheung started his career as surgeon at Queen Mary Hospital. With his interest in complicated liver surgery and liver transplantation, he became a staff member of the Division of Hepatobiliary and Pancreatic Surgery in 2006.
Dr. Cheung is one of the leading experts in laparoscopic liver resection in Hong Kong. He has performed more than 300 pure laparoscopic liver hepatectomies in Hong Kong. He published the results of laparoscopic hepatectomies at Queen Mary Hospital in various journals, including Annals of Surgery and World Journal of Surgery.
He is keen on new procedure development and is an active researcher in the fields of liver transplant, complicated liver surgery, ALPPS, minimally invasive surgery for liver cancer, and the role of dual tracer PET CT in the diagnosis of HCC. Dr. Cheung has obtained his doctoral degree (Master of Surgery, HKU) with research on the treatment of HCC in liver cirrhosis. He is the world’s leading expert in the area of high intensity focused ultrasound (HIFU) therapy for HCC. He performed the first HIFU treatment as a bridging therapy for liver transplant in the world.
Dr. Cheung was a recipient of the GB Ong Travelling Fellowship Award. He has won many other awards including travelling awards, Best Oral Presentation awards, Best Video awards and Best Poster awards in various international meetings. He has authored more than 140 peer-reviewed articles and other publications, and is frequently invited to lecture internationally and to present in plenary sessions. He has mentored a large number of trainees.
liver transplant, complicated liver surgery, ALPPS, minimally invasive surgery
Dr. Hongping Xia received his M.D. degree from Wannan Medical College in 2004 and Ph.D. degree from the University of Hong Kong in 2011. He has been a Visiting Scholar in the Medical University of Vienna and a Clinician Scientist of Yijishan Hospital of Wannan Medical College. He is currently a Professor of Nanjing Medical University and a Research Fellow of National Cancer Center Singapore.
Molecular pathology & translational medicine
Principal Investigator of several national grants, such as The National Natural Science Foundation of China (NSFC, China) and National Medical Research Council (NMRC, Singapore). His studies have been published in the leading international journals including Hepatology, Journal of Hepatology, Gut, ACS Nano, and J Biol Chem, etc.
Dr Tornesello Maria Lina is Head of Viral and Tumour Marker Section in the Molecular Biology and Viral Oncology Laboratory at the National Cancer Institute Fond Pascale in Napoli – Italy. She graduated in Biological Science from the University of Naples Federico II in 1988 and received the specialty degree in Microbiology and Virology from the School of Medicine, at the University of Naples Federico II in 1994. She is involved in the study of the cooperation of oncogenic viruses and other cofactors including host susceptibility and accumulation of genetic alterations in the carcinogenesis of virus-driven tumors.
Pathogenesis of hepatitis related liver cancer
Toxicology; nanotechnology and food safety
Professor Pietro Andreone graduated from the University of Bologna (Italy) School of Medicine and Surgery in 1980 and completed his training in Internal Medicine attaining Fellowship in 1989. In the same year he was appointed as Assistant Professor and from 2005 as Associate Professor of Internal Medicine in the Department of Medical and Surgical Sciences at the University of Bologna. From 1991 he is the leader of a research group and has had continuous funding from several research institutions. His research field are the diseases of the liver with special interest in viral hepatitis, cirrhosis, hepatocellular carcinoma, liver immunology, liver transplantation and liver stem cells. Professor Andreone has published 193 peer reviewed publications with a h-index of 40. He has or has had several collaborations with international research groups. He is the Director of the Program for the Diagnosis and Treatment of Chronic Viral Hepatitis at the University Hospital of Bologna. He has been the principal investigator in over 70 clinical studies especially in the field of innovative therapies for hepatitis C, hepatitis B and autoimmune liver diseases.
1. Liver cirrhosis
2. Hepatocellular carcinoma
3. Liver transplantation
4. Liver immunology
5. Liver stem cells
6. Chronic hepatitis
Stephen J. Beebe, molecular cell biologist / biochemist received his PhD in 1982 from the Medical College of Ohio, (now the Medical School at University of Toledo) in Medical Sciences (Pharmacology/ Biochemistry). He was a post-doctoral fellow at the Howard Hughes Medical Institute and Department of Molecular Physiology and Biophysics at Vanderbilt University, Nashville Tennessee. He was Fulbright Scholar at the University of Oslo, Norway and at the National Hospital and Department of Medical Biochemistry before taking a position as Assistant Professor in the Jones Institute for Reproductive Medicine and then an Associate Professor in the Department of Physiological Science and the Center for Pediatric Research at Eastern Virginia Medical School in Norfolk, Virginia. He is now a Professor at Old Dominion University in the Frank Reidy Research Center for Bioelectrics in Norfolk Virginia.
Physiological sciences; pediatric
Prof. Giulio Belli obtained his MD degree from University of Naples in 1975. He is the Head of General and HPB Surgery, Loreto Nuovo Hospital, Naples, Italy since 2000. He is Founder member of the World Association of HepatoBilairyPancreatic Association (WHBPA), Former member of the Scientific Committee of International HepatoPancreatoBiliary Association (IHPBA), Former Member of the Council of the European Hepato-Pancreato-Biliary Association (EHPBA), Founder and Member of the Council of International HepatoPancreatoBiliary Association-Italian Chapter (IT-IHPBA), etc. He serves as Editorial Board Member and Reviewer for many famous journals. Also he is author of 11 HPB book chapters, Invited Speaker in 105 National and 61 International Congress, and author of 351 pubblications.
General and vascular surgery
1. Embryonic stem cells
2. Liver regeneration
3. Liver transplantation.
4. Liver stem cells
Kenneth Siu-HoChok a specialist in general surgery based in Hong Kong, where he is Clinical Associate Professor in the Department of Surgery, the University of Hong Kong; Honorary Consultant in the Departments of Surgery at Queen Mary and Tung Wah Hospitals; Deputy Director of the Liver Transplant Centre and Director of High Dependency Unit (Surgery) at Queen Mary Hospital.
Dr Chok received his MBBS from the University of Hong Kong. In 2007, he attained his fellowship with the Hong Kong Academy of Medicine (Surgery) and became Deputy Chief of Residents at Queen Mary Hospital’sDepartment of Surgery, shortly progressing to Associate Consultant in 2008 and Consultant in 2011 at the age of 35. Dr Chok received his Master of Surgery from the University of Hong Kong in 2015 and became a fellow of the American College of Surgeons (ACS) in 2016 after having received the Carlos Pellegrini Traveling Fellowship award of the ACS. He is a famous Endoscopic-Laparoscopic HBP and Liver Transplant Surgeon in the territory.
Dr Chok has so far published 150 articles in leading peer-review journals on liver surgery and hepatocellular carcinoma, including Journal of Gastrointestinal Surgery, Surgery, World Journal of Surgery, Hepatology and Annals of Surgery. He is also a reviewer for many of these journals and frequently delivering lectures in various international meetings. Aside from hisoutstanding clinical and research duties, Dr Chok is actively involved in promoting organ donation in Hong Kong and is currently the Honorary Treasurer for the Hong Kong Society of Transplantation.
1. Extensive experience in managing all areas of complicated hepatobiliary, pancreatic diseases, deceased donor and living donor liver transplantation (including most technically demanding major vascular resection in HBP surgery, in-situ splitting and sequential liver transplantations)
2. Extensive experience in managing complex surgical problems in conjunction with other procedures (e.g. colectomy with synchronous liver resection)
3. Extensive experience in supervising different levels of surgeons
Dr. Di Fazio graduated as Biologist at University of Palermo in 2004. He worked as Research Fellow at Department of Pathology & Experimental and Clinical Medicine at University of Udine (2004/2005). He achieved his doctorate in Experimental Oncobiology (2007) at Department of Biochemical Sciences at University of Palermo where he started his PostDoc career. He was awarded of a fellowship from University of Palermo and a Short Term Fellowship from EASL. He moved to University of Marburg (2009) being awarded with a Sheila Sherlock PostDoc Fellowship from the European Association for the Study of the Liver (EASL). Since 2011, he is a permanent scientist at Marburg University at the Department of Visceral Thoracic and Vascular Surgery studying liver, thyroid and pancreas pathogenesis, apoptosis, ER stress and autophagy.
Liver fibrosis; cirrhosis and cancer; canonical and alternative mechanisms of cell death (ER stress, autophagy) and miRNAs activity in tumors
Dr. Pinar Erkekoglu is graduated from Hacettepe University Faculty of Pharmacy (BS) and Anadolu University Public Relations School (BS). She completed a part her PhD studies in Grenoble, France in Universite Joseph Fourier and CEA/INAC/LAN after receiving full scholarship from both European Union Erasmus Scholarship Program and from CEA. She worked as a post-doc and visiting associate in MIT (Massachusetts Institute of Technology) Biological Engineering Department between 2011 and 2012. Her main interests are the reproductive disorders, and oxidative stress induced by endocrine disrupting chemicals, particularly by phthalates, the protective role of selenium against oxidative stress and the toxic effects of aromatic amines. She has published more than 90 papers in national and international peer-reviewed journals and is currently working as an associate professor in Hacettepe University Faculty of Pharmacy Department of Pharmaceutical Toxicology. She is a European Registered Toxicologist (ERT) since 2014
Toxicology studies; male reproductive disorders
Dr. Lynn Feun is a medical oncologist in Miami, Florida and is affiliated with multiple hospitals in the area, including Jackson Memorial Hospital and Miami Veterans Affairs Healthcare System. He received his medical degree from Wayne State University School of Medicine and has been in practice for more than 20 years. Dr. Feun accepts several types of health insurance, listed below. He is one of 21 doctors at Jackson Memorial Hospital and one of 14 at Miami Veterans Affairs Healthcare System who specialize in Medical Oncology.
Developmental therapeutics; medicine; oncology
Samuel French is a liver pathologist and scientist who has been on faculty at the UCLA Department of Pathology since 2002. Dr. French earned his B.A. in Biophysics at U.C. Berkeley and M.D. and Ph.D. in Biochemistry at the University of Pittsburgh. He completed his residency in Pathology at UCLA as well as fellowship in gastrointestinal/liver pathology. He was a postdoctoral fellow at ucla where he worked on lymphomagenesis. He is a recipien of the Boyer-Parvin Postdoctoral Recognition Award and Cure Named New Investigator Award. Dr. French is currently developing a proteomic based program to study the developoment of liver cancer from hepatitis C viral infection.
Anatomic pathology; surgical pathology
Dr. Geller is the Richard L. Simmons Professor of Surgery at the University of Pittsburgh School of Medicine, and Director of the UPMC Liver Cancer Center. As a hepatobiliary Surgical Oncologist, his clinical interests center on the evaluation and management of patients with liver cancers.
He has pioneered laparoscopic liver resection surgery. Dr. Geller and his team have performed more than 800 of these cases. Most of these patients are discharged home on the second post-operative day with 4-5 bandaid-sized incisions. He also specializes in performing laparoscopic radiofrequency ablations of liver tumors.
Dr. Geller is a member of many professional and scientific societies including the Society of Surgical Oncology, Society of University Surgeons, and the American Society of Transplant Surgeons.
Dr. Geller has published 280 scientific papers and chapters. He is often a guest lecturer speaking on the management of liver tumors and has presented at more than 360 meetings or seminars. He has active research grants from the NIH, and is also the Principal Investigator on Industry-sponsored clinical trials for liver cancer.
Antonio Giorgio was graduated in Federico II University Naples, Italy. Founder and Director of Interventional Ultrasound Unit D. Cotugno” Hospital - Naples, Italy. His clinical and research activity is mainly focused on the ultrasound of liver diseases and ultrasound guided percutaneous treatment of HCC on cirrhosis, hydatid, abdominal abscesses and metastatic tumors of the liver and, more recently, intrahepatic cholangiocarcinoma.
He is author of more than 350 scientific publications.
He is author of many chapters in texts prepared by other authors, in general about ultrasound diagnostics (some of these are: Italian Treaty on Ultrasound - 2000, Atlas of Abdominal Ultrasound – 2003, Ultrasound in Internal Medicine - 2008).
Ultrasound diagnostics in liver diseases and the ultrasound guided percutaneous treatment of HCC on cirrhosis; hydatid and simple liver cysts; abdominal abscesses and metastatic tumors of the liver and, more recently; intrahepatic cholangiocarcinoma
Medical professor Yong-Song Guan is male, advisor of medical masters, mentor of medical doctorate and post-doctoral students. He is now a teacher in Sichuan University, an expert physician in Department of Oncology and Radiology of West China Hospital, and a post-retention member of State Key Laboratory of Biotherapy. He has been invited to serve as a member of the editorial board or reviewers of more than a dozen of medical journals home and abroad (many of the journals are indexed by SCI or MEDLINE). He has started his interventional career since 1986, and gained his experience in interventional diagnosis and management of more than 40,000 cases. He is good at the diagnosis and treatment of various difficult and stubborn diseases. He has been granted currently several research projects and fundations. He has been awarded several prizes, including Science and Technology Progress, 4 by Sichuan province government, one by Sichuan hygiene hall, 2 by Chengdu municipal government, and 7 excellent publication prizes by the province and municipality.
Gastroenterology and Hepatology
3. 3D imaging, X-ray computer
5. cancer gene therapy
6. carcinogenesis models
7. Diagnostic imaging
8. interventional therapy
9. Medical problem solving
10. Molecular Imaging
Professor Sen-Yung Hsieh earned his MD degree from the National Yang Ming University in 1983, and obtained his PhD in Molecular Virology and Pathology from University of Pennsylvania in 1991. He received his clinical training in internal medicine, and subsequent a specialty in hepatogastroenterology in Chang Gung Memorial Hospital, Linko, Taiwan.
He initially focused on the molecular virology and epidemiology of human hepatitis viruses. His team for the first time identified the zoonotic transmission of hepatitis E virus from swine to humans in 1998, which was later found in other wild and domestic animals as natural reservoirs for sporadic hepatitis E in Japan and western countries. Currently, Dr. Hsieh is interested in elucidation the molecular mechanisms involving in carcinogenesis of human hepatoma. By integration of both functional genomics and proteomics approaches, he has identified novel oncogenes, tumor suppressor genes, and pathways that play significant roles in oncogenesis of human hepatoma. His works have been published in J Virology, Nucleic Acid Res, PNAS, Cancer Research, Oncogene, Proteomics, J Proteome Res, Mol Cell Proteomics, J Hepatology, and Hepatology.
1. Gastroenterology and hepatobiliary diseases
2. Hepatitis and hepatoma
3. The molecular mechanisms of hepatocellular carcinogenesis using the molecular and cellular biology, genomics and proteomics approaches.
4. Molecular virology and epidemiology of human hepatitis viruses
5. Hepatocellular carcinoma: carcinogenesis mechanisms, diagnosis, and treatments Functional genomics for novel genes and pathways implicated in hepatocellular carcinogenesis
Toru Ishikawa, Ph D, M.D., General Manager of Gastroenterology, Saiseikai Niigata Daini Hospital from 2008 to now. From 1992 to 1993, Ishikawa was a Resident in the Niigata University Hospital, Niigata, Japan. From 1993 to 1994, Ishikawa was a Resident in the Sinrakuen Hospital, Niigata, Japan. From 1994 to 1995, Ishikawa was a medical Staff in the Saiseikai Niigata Daini Hospital, Niigata, Japan. From 1995 to 2002, Ishikawa was a Resident in the the Third Department of Internal Medicine in the Niigata University Hospital, Niigata, Japan. From 2002 to 2007, Ishikawa was a Head Doctor of Gastroenterology, Saiseikai Niigata Daini Hospital.
Hepatocellular carcinoma; portal hypertension; hepatitis
The Dr Kayaalp was graduated as a Doctor of Medicine in 1989 from Hacettepe University.
The Dr Kayaalp's surgical education included Ankara Numune Hospital, General Surgery Department and Yuksek Ihtisas Hospital Department of Gastrointestinal Surgery. He has been studying at Inonu University, Department of General Surgery since 2005. Liver surgery is one of my favorite topics. He has several national and international studies about liver surgery. He is a member of Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association, Turkish Society of Gastroenterology and IASGO (International Association of Surgeons Gastroenterologists and Oncologists).
General surgery; gastrointestinal surgery; gastrointestinal and hepato-biliary-pancreatic surgery
Genomics; proteomics and systems biology of HCC including biomarker discovery and validation; and personalized medicine
Experimental hepatology and drug targeting; biomedical investigation in liver and gastrointestinal diseases
T. B. Ng obtained his Ph.D. degree from the Memorial University of Newfoundland in Canada. He pursued postdoctoral training at the University of California in San Francisco. He is currently a professor of biochemistry at the School of Biomedical Sciences, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong, China. His research interests encompass biologically active proteins and peptides of animal, plant, fungal and bacterial origins; polysaccharide-peptide complexe; polysaccharides; melatonin and derivatives; and natural products. He has supervised a large number of postdoctoral fellows and graduate students.He has published over five hundred papers in international journals and a number of book chapters.Some of these papers are about leguminous lectins, antifungal proteins, ribosome inactivating proteins, protease inhibitors, and peroxidases. He serves as the editorial board memeber of several journals including International Journal of Peptides, Journal of Biochemistry and Molecular Biology in the Post Genomic Era,and Frontiers in Cellulose Biotechnology. He has reviewed research grant applications and manuscripts submitted to various journals for publications.
1. proteins and peptides of human, plant, bacterial and fungal origins with antifungal, antibacterial and antiviral activities such as defensins, cathelicidin and lactoferrin and their mechanisms of action; many novel proteins and peptides were discovered during the course of investigation
2. isolation and characterization of enzymes of human, plant, bacterial and fungal origins including proteases, laccases, ribonucleases, deoxyribonucleases, phytases, cellulases, superoxide dismutases, peroxidases and lysozyme
3. isolation and characterization of various bovine milk proteins;several novel proteins were discovered during the course of investigation
4. proteins and peptides with anticancer activity in tumor-bearing animals, antiproliferative activity toward cancer cells and immunomodulatory activity such as lectins, ribosome inactivating proteins, ribonucleases, protease inhibitors, defensins, and cathelicidin and their mechanisms of action
5. roles of the receptors of the hormones melatonin and leptin in the etiology of adolescent idiopathic scoliosis; biological activities of the pineal hormone melatonin and its biosynthetic relatives
6. pharmacological activities such as antioxidant, antidiabetic, anticancer, and steroidogenic activities of medicinal plants including American ginseng, Chinese ginseng, sanchi ginseng, Codonopsis pilosula, bitter gourd, Trichosanthes, yam, and Dendrobium, herbal formulas such as Erxian decoction and Tian Xian liquid, and medicinal mushrooms such as Ganoderma, Coriolus versicolor, and Cordyceps
Dr. Raza graduated from the Sind Med Coll, Univ of Karachi, Karachi, Pakistan in 1982. She works in Loma Linda, CA and 1 other location and specializes in Anatomic Pathology & Clinical Pathology and Cytopathology. Dr. Raza is affiliated with Loma Linda University Medical Center, Loma Linda University Medical East and Loma Linda University Surgical Hospital.
Anatomic pathology & clinical pathology;surgical pathology; cytopathology
Prof. Sergio Sartori was born on June 22, 1954, and graduated cum laude in 1979. He is specialist in Gastroenterology and in Clinical Pharmacology, is dealing with interventional ultrasonography from 1990, and from 2002 is Chief of the Section of Interventional Ultrasound, St. Anna Hospital, Ferrara, Italy. He is author of more than 246 scientific papers.
Interventional ultrasound; endoscopy
Dr. Shilpa Sharma is a faculty (Asst. Professor) of Pediatric Surgery at All India Institute of Medical Sciences, New Delhi. Her qualifications include MBBS - 1996, MS Gen Surgery -1999, MCh and DNB - Pediatric Surgery - 2004. She is involved in the surgical care of children since last 15 years with research interests in stem cells. She has also done PhD on stem cells from All India Institute of Medical Sciences, New Delhi in 2010. Her notable awards include Dr. Shoor Vir Singh Prize, UC Chakravorty Research Award, Shanti Talwar Fellowship, Swapan Datta Research Award, Purushotom Upadhyay Research Award for the best paper published in 2010, James Lister fellowship of the British Association of Pediatric Surgeons in 2012 and the WOFAPS scholarship from the World Federation of Association of Pediatric Surgeons 2014 under which she was a fellow at GOS Hospital for Children at London, UK. She has published 56 research papers and 80 book chapters, delivered more than 60 guest lectures and presented more than 110 papers at various national and international conferences. She has served as an Editorial Assistant for Journal of Indian Association of Pediatric Surgeons and is presently an Editorial Consultant for two International journals apart from being a reviewer of many peer reviewed journals. She has served as Secretary of the Delhi chapter of Indian Association of Pediatric Surgeons from 2011-2014 and is currently the Secretary of the Research Section of the Indian Association of Pediatric Surgeons since 2011.
Nicola Silvestris graduated cum laude in 1993 from the Catholic University of Rome School of Medicine, Rome, Italy. He received his Ph.D. degree in 1998. Since graduation, he has become involved in studies on translational research in solid tumors. In this area, he is recognized as a national and international expert, as indicated by the numerous participations in meetings and seminars as an invited speaker. From 2011 he has been involved in the elaboration of guidelines of exocrine pancreatic carcinoma for the Italian Association of Medical Oncology. Since 2015, he is a Founding Member of the Italian Group for Diagnosis and Treatment of Biliary Cancer (GICO). He has published more than 140 papers in peer-reviewed journals. He regularly serves as a reviewer for the most important gastroenterology journals and for funding agencies.
Translational research (predictive and prognostic markers in gastrointestinal malignancies); treatment of gastrointestinal malignancies; conduction of clinical trials
Dr. Tombesi was born on April 27, 1976, and graduated cum laude in 2001. She is specialist in Internal Medicine and is dealing with interventional ultrasonography from 2003. She is working in the Section of Interventional Ultrasound, St. Anna Hospital, Ferrara, Italy, from 2006, and is author of 62 scientific papers.
Dr. Georgios Tsoulfas received his medical degree from Brown University School of Medicine and completed his general surgery residency at the University of Iowa Hospitals and Clinics, as well as a transplant research fellowship at the Starzl Transplant Institute at the University of Pittsburgh. He then completed a two-year transplantation surgery fellowship at the Massachusetts General Hospital, Harvard Medical School and then joined the Division of Solid Organ Transplantation and Hepatobiliary Surgery at the University of Rochester Medical Center as an assistant professor of surgery. He has recently returned to Greece where he is an Assistant Professor of Surgery at the Aristoteleion University of Thessaloniki.The recipient of awards such as the Edward E. Mason award for excellence in patient care and education and a member of the American Society of Transplant Surgeons Bylaws Committee, he is a member of a number of professional organizations including the American Society of Transplant Surgeons, Association for Academic Surgery, International College of Surgeons, American College of Surgeons, International Liver Transplantation Society, American Medical Association, Society for Laparoscopic Surgeons and International HepaticoPancreaticoBilliary Association.
Solid organ transplantation and hepatobiliary surgery
Dr. Yamaguchi graduated from Shizuoka College of Pharmacy (B.S.) in 1971 and obtained Ph.D of Pharmaceutical Sciences in 1976. He was engaged as Research Associate and Assistant Professor in Shizuoka College of Pharmacy (1973-1987). As Assistant Professor in School of Pharmaceutical Sciences, University of Shizuoka(1987-1991). As Associated Professor in University of Shizuoka, Graduate School of Nutritional Sciences (1991-1993) and Professor in University of Shizuoka, Graduate School of Nutritional Sciences (1993 ~ 2007) in Japan. From 2007, Yamaguchi was invited as Visiting Professor, Emory University School of Medicine, Department of Medicine. He was appointed Editorial Board Member of many Journals including International Journal of Molecular Medicine, Molecular Medicine Reports, Journal of Osteoporosis, International Journal of Medicine and Medical Sciences, International Journal of Nutrition and Metabolism, Molecular and Cellular Biochemistry, Endocrinology Studies, Alternative Medicine Studies, Experimental and Therapeutic Medicine, and Stem Cell Discovery. Yamaguchi published over 500 English original papers, review articles and books.
Hematology and biomedical oncology
My research commits to explore the changes of noncoding RNA expression profiles and regulatory networks in the progress of hepatocellular carcinoma (HCC). As the first author, I had published 12 papers in leading journals of medicine, such as Mol Cell and Hepatology. There are two representative papers were recommended and evaluated by Faculty of 1000 experts. Also, my research won several academic prizes, including “ShangHai Outstanding Ph.D. Thesis” and Second Prize of Shanghai Natural Science Award. Moreover, I had been selected as a member in several talent schemes, such as Shanghai Risingstar in Science and Technology.
Hepatocellular carcinoma; Noncoding RNA; Epigenetics
Yang is a professor of Institute of Medicine, Chung Shan Medical University, Taiwan. He has received the Ph.D. degree in molecular biology. In particular, his researches have been focused on pharmacology, cancer metastasis, cancer biology, genetic polymorphism and environment risk factors in cancer.
Pharmacology; cancer metastasis; cancer biology; genetic polymorphism and environment risk factors in cancer
Hiroshi Yoshida, M.D. is graduated from Nippon Medical School (Bsc) obtained MD and subsequently entered the Department of Surgery in 1986. From 1988 to 1992, He attended Postgraduate course in Department of Surgery, Nippon Medical School and obtained PhD. In 1992, He was appointed clinical fellow of the Department of Surgery, Nippon Medical School. In 2003, He was appointed assistant professor and, in 2005, associated professor of the Department of Surgery, Nippon Medical School. In 2010, He was appointed associated professor of the Department of Surgery, Nippon Medical School Tama Nagayama Hospital. In 2011, he was appointed Chief and Clinical Professor of the Department of Surgery, Nippon Medical School Tama Nagayama Hospital. In 2014, he was appointed Assistant Director of the Nippon Medical School Tama Nagayama Hospital.
Hepato-biliary-pancreatic surgery; portal hypertension; transplantation; interventional radiology; endoscopic treatment
Dr. Yanmin Zhang is a full professor of School of Pharmacy, Health Science Center, Xi'an Jiaotong University of China, member of Chinese Pharmaceutical Association. Yanmin Zhang received his B.S. in chemistry and Ph.D. in pharmaceutical analysis. He began his independent career in 1999. He is currently the director of molecular pharmacology program and assistant research scientist in the Biodesign Institute of Arizona State University, USA. He has held more than 10 national projects, published more than 100 papers including Pharmacol Therapeut, JACS, Org Lett, Chem Commu, CDDs, Sci Rep, Can lett, JCMM , et al. and held 26 patents.
Tumor Cell Biology
Screening of targeted drug